The first shot of the Sino-US trade war started! A large number of pharmaceutical companies

Medical Network July 9th The Sino-US trade war finally broke out.

According to Xinhua News Agency, the United States imposed a 25% import tariff on the first batch of 818 categories and $34 billion worth of Chinese goods on July 6 at 00:01 local time (Beijing time at 12:01 on the 6th). .

The spokesperson of the Ministry of Commerce of China immediately responded that the Chinese side had to be forced to make necessary counterattacks in order to defend the core interests of the country and the interests of the people. Beijing 12:01, Beijing, China’s counter-measures against the United States were officially implemented, involving agricultural products. , 545 items such as automobiles, about 34 billion US dollars of goods.

From March, the United States imposed tariffs on imported steel and aluminum products, and in April announced a list of 301 investigation taxation proposals related to China’s $50 billion export, and then threatened to set up a $200 billion taxation list, the entire Sino-US trade friction process. It has always been a move by the United States, China has taken over, and China has always exercised restraint.

According to the latest list, all drug And some low-end medical devices were removed, on the grounds that 'taxation may lead to a large number of Chinese medicine Products abandon the US market, and suppliers from other countries need to pass the FDA's long approval process and cannot fill market demand in a short period of time'.

Although the trade war is currently not directly related to pharmaceuticals enterprise However, during this period, Trump has called the US pharmaceutical companies more than once.

On January 11, 2017, Trump slammed the pharmaceutical industry for the first time since the election, because pharmaceutical companies prefer to produce drugs overseas, not the United States. To this end, he shouted: The pharmaceutical industry must be returned Native American!

At the same time, Trump accused pharmaceutical companies of charging high prices for drugs as 'unpunished murder' and promised to change the current situation, triggering biopharmaceutical stocks to fall. In just 20 minutes of the press conference, let 9 medicines The company evaporated nearly $24.6 billion.

At the end of May this year, Trump announced the launch of the US patient priority strategy. He said that American companies have incurred high R&D costs, and some foreigners have been 'popting cheaply' and have ordered this to be the top priority of trade negotiations.

He also said that some big pharmaceutical companies will announce the price reduction of voluntary drugs within two weeks, and the price of prescription drugs is expected to drop sharply.

According to the Financial Times, just a month after Trump made the above remarks, Pfizer, the largest independent pharmaceutical company in the United States, sang a counter-tune and once again greatly increased the price of medicines.

According to the report, Pfizer has increased the price of 100 kinds of drugs it produces. Most of the price increases are slightly higher than 9%, which is much higher than the current inflation rate of about 2% in the US. The price increase list includes Ruihui's most famous. The drug 'Viagra', the price adjustment has taken effect on July 1.

We can find that today's trade war started, the A-share pharmaceutical manufacturing sector has basically no impact, the sector rose 0.01%, 211 pharmaceutical stocks (excluding suspension), only 86 stocks fell.

Although there is no medicine in the first list of trade wars, only part medical instruments However, Trump said on July 5 that if China takes revenge, the United States will start the current taxation on the import of Chinese goods worth 200 billion U.S. dollars, and then start the current suspension of imports of Chinese goods to US$300 billion as needed. Taxation.

According to the US National Bureau of Statistics, the total amount of goods imported from China in 2017 is 505.4 billion US dollars. That is to say, the United States may increase tariffs on all imported goods from China. At this time, Chinese pharmaceutical companies Must pay close attention to and take precautions in advance.

Earlier, Deborah Elms, executive director of the Asia Trade Center in Singapore, said in an interview that pharmaceutical companies that have established overseas supply chains should be especially wary of Trump's threat of import duties on foreign-made goods. She said that for this industry, this is a very vague problem. 'Increased tax on import taxes, it is obviously only able to crack down on drugs that are manufactured abroad and imported back to the US, not tariffs.'

Important points of the trade war in the future stage: